Viewing Study NCT00754351


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2025-12-25 @ 9:47 PM
Study NCT ID: NCT00754351
Status: COMPLETED
Last Update Posted: 2012-06-28
First Post: 2008-09-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
Sponsor: University Hospital of Crete
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module